💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @InsiderAlerts4U | 9 |
| @FlashAlert_me | 8 |
| @formwhisperscom | 8 |
| @Tickeron | 5 |
| @InsiderForms | 4 |
Recent Tweets for FATE
 |
@mediasentiment $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 161 January 25th 2022, 9:01am |
 |
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's President and CEO J SCOTT WOLCHKO: https://t.co/vwnUHSVLQj January 24th 2022, 10:01pm |
 |
@mehabecapital Insider Activity seen in $FATE, Wolchko J Scott (President and C) Option Exercise, Total-Shares = 10,000, Transact… https://t.co/2p6NMTn7cs January 24th 2022, 9:01pm |
|
@mehabecapital Insider Activity seen in $FATE, Wolchko J Scott (President and C) Option Exercise, Total-Shares = 30,000, Transact… https://t.co/npY5V5ZgiG January 24th 2022, 9:01pm |
 |
@bonjour247 RT @bonjour247: $FATE a @CathieDWood name.. about to enter the "Price-Volume Vacuum" (tm) .. Street love humping here, but I dunno, $7b for… January 24th 2022, 5:01pm |
 |
@Gukie71 RT @TheATGCSeeker: Interested to hear the bull and bear cases for $FATE at these levels if anyone can kindly share their two cents [email protected]_May_… January 24th 2022, 1:01pm |
 |
@TheATGCSeeker Interested to hear the bull and bear cases for $FATE at these levels if anyone can kindly share their two cents ?… https://t.co/RiGwSC1qSU January 24th 2022, 10:01am |
 |
@Sarah_Katilyn $FATE there's so many more but I'll leave it this. Interested to see what takes place in the sector overall over th… https://t.co/FFOgXQenv7 January 23rd 2022, 11:01pm |
 |
@Tickeron $FATE's 10-day Moving Average crossed below its 50-day Moving Average on January 10, 2022. View odds for this and o… https://t.co/HgtVCFya3l January 23rd 2022, 2:01pm |
 |
@ironicpoor RT @Tickeron: A.I.dvisor made a bearish call on $FATE, netting in a 30.16% gain over 2 months #FateTherapeutics #stockmarket #stock https:/… January 23rd 2022, 1:01pm |
 |
@DylanStanton007 $FATE... What will be the fate? January 23rd 2022, 1:01pm |
|
@Tickeron A.I.dvisor made a bearish call on $FATE, netting in a 30.16% gain over 2 months #FateTherapeutics #stockmarket… https://t.co/kKZPiiEGJ5 January 23rd 2022, 1:01pm |
 |
@JamesPe11062557 @lmj612 @AnExpertOne1 Dr. Dan Kaufman, was one of the co-founders and is CSO. Without him, $FATE wouldn't be where… https://t.co/awpDZoZLtd January 22nd 2022, 8:01pm |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in FATE THERAPEUTICS INC. COMMON $FATE https://t.co/jLO8lFfncW January 22nd 2022, 6:01pm |
|
@Tickeron A.I.dvisor made a bearish call on $FATE, netting in a 30.16% gain over 2 months #FateTherapeutics #stockmarket… https://t.co/8JJJtYTvY0 January 22nd 2022, 6:01pm |
 |
@MrMilesLong12 $FATE Can people email IR and ask them to upload all the (pre)clinical posters they have presented at scientific/me… https://t.co/fHpq5IvSxk January 21st 2022, 8:01pm |
 |
@WCryosleep @bearcapital1 @Biotech2k1 $FATE has provided great liquidity to reap huge gains, don’t forget the macro backdrop’s impact on prices tho ? January 21st 2022, 2:01pm |
 |
@bearcapital1 @WCryosleep @Biotech2k1 Check my tweets on $FATE for last 60 points +. I’ve never had one kind word for them lol January 21st 2022, 1:01pm |
 |
@Biotech2k1 @WCryosleep @bearcapital1 I don't even like $BLU. No offense to our friend who does. When I compare it to $FATE, I… https://t.co/iDeqPgFIRM January 21st 2022, 1:01pm |
|
@bearcapital1 @WCryosleep @Biotech2k1 $BLU has pretty nice liquidity. Think its a superior investment to $FATE January 21st 2022, 1:01pm |
|
@WCryosleep @bearcapital1 @Biotech2k1 Not going to recommend any actually liquid midcap stocks that you think will outperform $FATE at today’s price? January 21st 2022, 1:01pm |
|
@bearcapital1 @Biotech2k1 3.6B of meh still even after a 67% pull back $FATE January 21st 2022, 12:01pm |
 |
@z7rw85jjgd @Biotech2k1 $FATE could also easily be a worth a quadrillion. So it’s quite cheap here imo. January 21st 2022, 11:01am |
 |
@riskrewardalgo @dhovekamp42 @FINVIZ_com PT $fate. For me is 10 dollars January 20th 2022, 10:01pm |
|
@Biotech2k1 My $FATE bid just triggered at $38.46 to overweight this stock at 4.23%. This is one of my oldest companies. I had… https://t.co/Vaz0JtkXkc January 20th 2022, 8:01pm |
 |
@Z3r03rr0r Rough plan for $FATE token on Alcor. It;s not complete and rough cause the charts are a bit hard to work with on t… https://t.co/jURjFhAkG7 January 20th 2022, 9:01am |
 |
@princetongb $FATE sub $40. Cathie has taken it back up each dip. Will she do it again? January 19th 2022, 7:01pm |
|
@Buckboy59191682 $FATE NIGHTMARE!!this isn’t ending any time soon..ECONOMY SUCKS ..give me REPUBLICAN RULE.. # January 19th 2022, 12:01am |
 |
@Immersys RT @Z3r03rr0r: $FATE needs volume... It looks like it wants do make a move here soon. Interesting chart though for such an early project.… January 16th 2022, 8:01pm |
|
@Z3r03rr0r $FATE needs volume... It looks like it wants do make a move here soon. Interesting chart though for such an early… https://t.co/tKtCMbHXQE January 16th 2022, 7:01pm |
 |
@JRMKE3 $FATE As 536 IND clearance news has passed—think it is reasonable to expect dosing to commence in October/November… https://t.co/IgaOVbwdlQ January 16th 2022, 6:01pm |
 |
@wallstreetmover Wedbush Analyst Reiterates Buy David Nierengarten, analyst at Wedbush, reiterates Buy Rating on $FATE with a price… https://t.co/Lx5HG7ZwzA January 16th 2022, 4:01pm |
|
@JRMKE3 $FATE We can probably add 819: BCL, ALL and CLL to ASH 22. January 15th 2022, 1:01pm |
|
@mediasentiment $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 93 January 15th 2022, 10:01am |
|
@mediasentiment $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 71 January 14th 2022, 10:01am |
 |
@kwhenfinance Fate Therapeutics Inc Shares Fall 3.2% Below Previous 52-Week Low - Market Mover https://t.co/rTDWXZHjJ6 $FATE #stockmarket #kwhenfinance January 14th 2022, 5:01am |
 |
@car_johnathan RT @DmitryKovalchuk: $FATE management is losing fate if you judge by these insider sellings. January 14th 2022, 3:01am |
|
@car_johnathan RT @BrianUherek: Bottom today? (new 52wk low) Speaking of price, if Affimed had a fraction of the banking support that $FATE enjoys investo… January 14th 2022, 3:01am |
 |
@MarcJacksonLA $FATE FDA clears IND application for CAR natural killer cell therapy to treat solid tumors https://t.co/uzaQbqmlJB January 14th 2022, 12:01am |
|
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in FATE THERAPEUTICS INC. COMMON $FATE https://t.co/dJRxYTLq0L January 14th 2022, 12:01am |
 |
@aistockfinder $FATE https://t.co/FxJVJaeOql Fate Therapeutics Inc. Our predictive algorithm calculated this equity has a negative… https://t.co/8Wy95Xg76S January 13th 2022, 11:01pm |
|
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's Chief R&D Officer BAHRAM VALAMEHR: https://t.co/3GG1GPZ9S2 January 13th 2022, 9:01pm |
|
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's President and CEO J SCOTT WOLCHKO: https://t.co/tCb7NXnBdr January 13th 2022, 9:01pm |
 |
@FrankHulskof @BrianUherek $FATE 40 in sight. 30 will come. $AFMD sub 4 also. Bio market is horrible. January 13th 2022, 9:01pm |
|
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's General Counsel and Secretary CINDY TAHL: https://t.co/W4ibvUFbGe January 13th 2022, 9:01pm |
 |
@ShortAlgoKing $FATE Almost ripe for a jump! Chart by https://t.co/qchl9O5K2n https://t.co/tbdL4K426h January 13th 2022, 9:01pm |
|
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's Chief Financial Officer EDWARD J III DULAC: https://t.co/v40JmDkClu January 13th 2022, 9:01pm |
 |
@day_trading_de FATE (FATE THERAPEUTICS INC) ? #Insider #stock alert! ? #Sale on 2022-01-11 - $FATE ??: TAHL CINDY (General Counsel… https://t.co/5eK5iheCdj January 13th 2022, 9:01pm |
|
@day_trading_de FATE (FATE THERAPEUTICS INC) ? #Insider #stock alert! ? #Sale on 2022-01-11 - $FATE ??: Wolchko J Scott (President… https://t.co/jYJLxz34Uw January 13th 2022, 9:01pm |
|
@InsiderAlerts4U $FATE: New Insider Filing on FATE THERAPEUTICS INC's Senior VP Clinical Development YU-WAYE CHU: https://t.co/xOc6s6Op7l January 13th 2022, 9:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?